GB202118110D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB202118110D0
GB202118110D0 GBGB2118110.2A GB202118110A GB202118110D0 GB 202118110 D0 GB202118110 D0 GB 202118110D0 GB 202118110 A GB202118110 A GB 202118110A GB 202118110 D0 GB202118110 D0 GB 202118110D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2118110.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vaccine Group Ltd
Original Assignee
Vaccine Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaccine Group Ltd filed Critical Vaccine Group Ltd
Priority to GBGB2118110.2A priority Critical patent/GB202118110D0/en
Publication of GB202118110D0 publication Critical patent/GB202118110D0/en
Ceased legal-status Critical Current

Links

GBGB2118110.2A 2021-12-14 2021-12-14 Vaccine Ceased GB202118110D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2118110.2A GB202118110D0 (en) 2021-12-14 2021-12-14 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2118110.2A GB202118110D0 (en) 2021-12-14 2021-12-14 Vaccine

Publications (1)

Publication Number Publication Date
GB202118110D0 true GB202118110D0 (en) 2022-01-26

Family

ID=80080136

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2118110.2A Ceased GB202118110D0 (en) 2021-12-14 2021-12-14 Vaccine

Country Status (1)

Country Link
GB (1) GB202118110D0 (en)

Similar Documents

Publication Publication Date Title
GB202010425D0 (en) Combination vaccine
GB202002166D0 (en) Vaccine
EP4159234A4 (en) Sars-cov-2 vaccine
EP4185323A4 (en) Aav5-based vaccine against sars-cov-2
IL292272A (en) Cancer vaccine
IL288673A (en) Tgf-beta vaccine
GB201910794D0 (en) Vaccine
GB201917699D0 (en) Vaccine conjugates
GB202016954D0 (en) Vaccine
GB202013262D0 (en) Vaccine Composition
GB201811382D0 (en) Vaccine
GB202119115D0 (en) Vaccine
GB202118110D0 (en) Vaccine
GB202114274D0 (en) SARS-CoV-2 vaccine
GB202112149D0 (en) Shigellla vaccine
GB202102677D0 (en) Vaccine
GB202016165D0 (en) Vaccine
GB202014719D0 (en) Vaccine
GB202013541D0 (en) Vaccine
GB202013534D0 (en) Vaccine
GB202013253D0 (en) Vaccine
GB202009402D0 (en) Vaccine
GB202005878D0 (en) Vaccine
GB202005880D0 (en) Vaccine
GB202003289D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)